Cargando…

Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer

SIMPLE SUMMARY: Colorectal cancer (CRC) is a frequently lethal disease with heterogenous outcomes. Alterations in the Wnt signaling pathways have been shown to promote activation of signaling pathways such as MAPK and PI3K-Akt. Consensus molecular subtyping (CMS) provides a cohesive structure to cla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunez, Sha’Kayla K., Young, Corey D., Griffen, Ti’ara L., Ohandjo, Adaugo Q., McKinney, Lawrence P., Kopetz, Scott, Lillard, James W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616344/ https://www.ncbi.nlm.nih.gov/pubmed/34830978 http://dx.doi.org/10.3390/cancers13225824

Ejemplares similares

Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival
por: Griffen, Ti’ara L., et al.
Publicado: (2021)

Transcriptome Network Analysis Identifies CXCL13-CXCR5 Signaling Modules in the Prostate Tumor Immune Microenvironment
por: Ohandjo, Adaugo Q., et al.
Publicado: (2019)

Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients
por: Adebayo, Olayinka O., et al.
Publicado: (2022)

A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer
por: Dill, Courtney D., et al.
Publicado: (2021)

Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer
por: Chowdhury, Saikat, et al.
Publicado: (2021)

The Consensus Molecular Subtypes of Colorectal Cancer
por: Guinney, Justin, et al.
Publicado: (2015)

Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant
por: Hoff, Fieke W., et al.
Publicado: (2022)

Proteomic profiling based classification of CLL provides prognostication for modern therapy and identifies novel therapeutic targets
por: Griffen, Ti’ara L., et al.
Publicado: (2022)

Prognostication of DNA Damage Response Protein Expression Patterns in Chronic Lymphocytic Leukemia
por: Griffen, Ti’ara L., et al.
Publicado: (2023)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer
por: Eide, Peter W., et al.
Publicado: (2021)

Investigation of colorectal cancer in accordance with consensus molecular subtype classification
por: Sawayama, Hiroshi, et al.
Publicado: (2020)

MmCMS: mouse models’ consensus molecular subtypes of colorectal cancer
por: Amirkhah, Raheleh, et al.
Publicado: (2023)

Reverse Phase Protein Array Profiling Identifies Recurrent Protein Expression Patterns of DNA Damage-Related Proteins across Acute and Chronic Leukemia: Samples from Adults and the Children’s Oncology Group
por: Hoff, Fieke W., et al.
Publicado: (2023)

Context matters—consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials
por: Fontana, E, et al.
Publicado: (2019)

Distinct gut microbiome patterns associate with consensus molecular subtypes of colorectal cancer
por: Purcell, Rachel V., et al.
Publicado: (2017)

Consensus Molecular Subtypes (CMS) in Metastatic Colorectal Cancer - Personalized Medicine Decision
por: Rebersek, Martina
Publicado: (2020)

YAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes
por: Mouillet-Richard, Sophie, et al.
Publicado: (2020)

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approach
por: Valenzuela, Guillermo, et al.
Publicado: (2021)

Genomic landscape and expression profile of consensus molecular subtype four of colorectal cancer
por: Lu, Yujie, et al.
Publicado: (2023)

Data supporting the identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells
por: Lee, Jin-Gyun, et al.
Publicado: (2014)

CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models
por: Eide, Peter W., et al.
Publicado: (2017)

Recent developments in the treatment of metastatic colorectal cancer
por: Loree, Jonathan M., et al.
Publicado: (2017)

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
por: van den Bulk, Jitske, et al.
Publicado: (2019)

Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis
por: ten Hoorn, Sanne, et al.
Publicado: (2021)

The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
por: Tanjak, Pariyada, et al.
Publicado: (2023)

Identifying essential genes in genome-scale metabolic models of consensus molecular subtypes of colorectal cancer
por: Cheng, Chao-Ting, et al.
Publicado: (2023)

Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer
por: Okita, Akira, et al.
Publicado: (2018)

Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning
por: Sirinukunwattana, Korsuk, et al.
Publicado: (2021)

Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
por: González-Montero, Jaime, et al.
Publicado: (2023)

Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer
por: Smeby, Jørgen, et al.
Publicado: (2019)

Image-based assessment of extracellular mucin-to-tumor area predicts consensus molecular subtypes (CMS) in colorectal cancer
por: Nguyen, Huu-Giao, et al.
Publicado: (2021)

A panel of DNA methylation markers for the classification of consensus molecular subtypes 2 and 3 in patients with colorectal cancer
por: van den Berg, Inge, et al.
Publicado: (2021)

Consensus clustering applied to multi-omics disease subtyping
por: Brière, Galadriel, et al.
Publicado: (2021)

Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1
por: Sveen, Anita, et al.
Publicado: (2017)

CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer
por: Loupakis, Fotios, et al.
Publicado: (2019)

Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
por: Laoukili, Jamila, et al.
Publicado: (2022)

Mechanisms of resistance to EGFR-targeted therapies in colorectal cancer: more than just genetics
por: Parseghian, Christine, et al.
Publicado: (2023)

Breast cancer subtype predictors revisited: from consensus to concordance?
por: MJ. Sontrop, Herman, et al.
Publicado: (2016)

Consensus molecular subtypes of primary colon tumors and their hepatic metastases
por: Lau, Yee Chen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sn49cdeklrk1segrrpl56lor2u